Ethical considerations of neuro-oncology trial design in the era of precision medicine
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ethical considerations of neuro-oncology trial design in the era of precision medicine
Authors
Keywords
Precision medicine, Neuro-oncology, n-of-1 trials, Clinical trial design, Medical ethics
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 134, Issue 1, Pages 1-7
Publisher
Springer Nature
Online
2017-05-29
DOI
10.1007/s11060-017-2502-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Translating Genomics in Cancer Care
- (2017) Yvonne Bombard et al. Journal of the National Comprehensive Cancer Network
- Patient and interest organizations’ views on personalized medicine: a qualitative study
- (2016) Isabelle Budin-Ljøsne et al. BMC Medical Ethics
- Precision medicine ethics
- (2016) Robin N. Fiore et al. CURRENT OPINION IN ONCOLOGY
- Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsidered
- (2016) Rhodé M Bijlsma et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Global trends on fears and concerns of genetic discrimination: a systematic literature review
- (2016) Annet Wauters et al. JOURNAL OF HUMAN GENETICS
- Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and Patients
- (2016) Fortunato Ciardiello et al. ONCOLOGIST
- A Survey of U.S Adults’ Opinions about Conduct of a Nationwide Precision Medicine Initiative® Cohort Study of Genes and Environment
- (2016) David J. Kaufman et al. PLoS One
- Drifting Away from Informed Consent in the Era of Personalized Medicine
- (2015) Erik Parens HASTINGS CENTER REPORT
- Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy
- (2015) Priscilla K. Brastianos et al. JNCI-Journal of the National Cancer Institute
- Ask Not What Personalized Medicine Can Do for You - Ask What You Can Do for Personalized Medicine
- (2015) Isabelle Budin-Ljøsne et al. Public Health Genomics
- Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy
- (2015) Priscilla K. Brastianos et al. JNCI-Journal of the National Cancer Institute
- Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility
- (2014) Angela R. Bradbury et al. GENETICS IN MEDICINE
- Genetic Information, Non-Discrimination, and Privacy Protections in Genetic Counseling Practice
- (2014) Anya E. R. Prince et al. Journal of Genetic Counseling
- Traditional Roles in a Non-Traditional Setting: Genetic Counseling in Precision Oncology
- (2014) Jessica N. Everett et al. Journal of Genetic Counseling
- Personalized Medicine, Availability, and Group Disparity: An Inquiry into How Physicians Perceive and Rate the Elements and Barriers of Personalized Medicine
- (2014) Katelin E. Petersen et al. Public Health Genomics
- Just caring: Assessing the ethical and economic costs of personalized medicine
- (2014) Leonard M. Fleck UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Integrating genomics into clinical oncology: Ethical and social challenges from proponents of personalized medicine
- (2014) Michelle L. McGowan et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Educating physicians in the era of genomic medicine
- (2014) Michael F Murray Genome Medicine
- Revealing the Incidentalome When Targeting the Tumor Genome
- (2013) Yvonne Bombard et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- “N of 1” case reports in the era of whole-genome sequencing
- (2013) A. Rose Brannon et al. JOURNAL OF CLINICAL INVESTIGATION
- A Patient-Focused Solution for Enrolling Clinical Trials in Rare and Selective Cancer Indications
- (2012) Eric B. Lynam et al. DRUG INFORMATION JOURNAL
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Feedback of individual genetic results to research participants: in favor of a qualified disclosure policy
- (2011) Annelien L. Bredenoord et al. HUMAN MUTATION
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing
- (2011) Nikhil Wagle et al. Cancer Discovery
- Views of Discrimination among Individuals Confronting Genetic Disease
- (2010) Robert Klitzman Journal of Genetic Counseling
- Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- (2008) Michael D. Prados et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now